- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada | 255 | Newsfile | Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via... ► Artikel lesen | |
| Mi | Rapid Dose Therapeutics Corp: Rapid Dose to issue 463,716 shares for note interest | 1 | Stockwatch | ||
| Mi | Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors | 281 | Newsfile | Burlington, Ontario--(Newsfile Corp. - April 1, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 19.02. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $5-million private placement | 2 | Stockwatch | ||
| 19.02. | Rapid Dose Therapeutics announces proposed equity private placement financing | 1 | Seeking Alpha | ||
| 18.02. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing | 382 | Newsfile | Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
| 29.01. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von QuickStrip® Nicotine | 265 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von... ► Artikel lesen | |
| 29.01. | Rapid Dose Therapeutics Corp: Rapid Dose continues deal with nicotine firm | 3 | Stockwatch | ||
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 29.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025 | 462 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (RDT), a Canadian biotechnology company working with an international company in oral nicotine products... ► Artikel lesen | |
| 28.01. | Rapid Dose Therapeutics Corp: Rapid Dose receives extension for debt settlement | 8 | Stockwatch | ||
| 27.01. | Rapid Dose Therapeutics receives extension to close its shares-for-debt deal | 3 | Seeking Alpha | ||
| 27.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement | 367 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated December 9, 2024... ► Artikel lesen | |
| 16.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees | 192 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares... ► Artikel lesen | |
| 08.01. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 430,930 shares as interest payment | 4 | Stockwatch | ||
| 07.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 383 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 24.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares for director fees | 3 | Stockwatch | ||
| 24.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 399 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 11.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose arranges $6-million private placement | 8 | Stockwatch | ||
| 10.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement | 435 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
| 06.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose applies for patent on Lidocaine film strip | 1 | Stockwatch |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 83,65 | -1,82 % | Lululemon | Ubisoft | Steyr - Curevac mit erstem Erfolg gegen Biontech | Markus Weingran - Mein Tipp: SMARTBROKER+: https://broker-tipp.de/ (Werbung) Willkommen bei der Börsenlounge mit Markus Weingran. Die Themen heute: Lululemon | Ubisoft | Steyr - Curevac mit erstem Erfolg... ► Artikel lesen | |
| CLINUVEL | 6,235 | -1,50 % | Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much | ||
| BIONXT SOLUTIONS | 0,350 | +2,04 % | Novo Nordisk, BioNxt Solutions, Bayer Aktie: Drei Wege zu Gesundheit und Rendite | Die Pharmabranche boomt - und drei Unternehmen stehen 2025 besonders im Rampenlicht: Novo Nordisk, BioNxt Solutions und Bayer. Alle drei verbindet ein Ziel: Mit innovativen Ansätzen die Gesundheit von... ► Artikel lesen | |
| HAVN LIFE SCIENCES | 0,013 | -100,00 % | HAVN Life Sciences Aktie: Ärger kommt auf?** | Das kanadische Biotech-Unternehmen für psychedelische Gesundheitslösungen kämpft mit Finanzierungsproblemen und unklaren Regulierungen in einem vielversprechenden Nischenmarkt. HAVN Life Sciences navigiert... ► Artikel lesen | |
| ATAI LIFE SCIENCES | 1,275 | +6,92 % | ATAI Life Sciences Aktie: Bericht über jüngste Finanztrends | Das Biotechnologie-Unternehmen erforscht innovative Substanzen gegen Depressionen und entwickelt neuartige Behandlungsmethoden für psychische Erkrankungen. ATAI Life Sciences treibt die Entwicklung... ► Artikel lesen | |
| VIDAC PHARMA | 0,570 | -1,72 % | Aktie vor 100 %-Rally! Evotec, thyssenkrupp, Vidac Pharma Aktie vor goldenem April? | Können sich Aktionäre bald über 100 % Kursgewinn freuen? Geht es nach Analysten, könnte dies bei Evotec bevorstehen. Allerdings müssen Aktionäre zuvor einen wichtigen Termin im April markieren. Dort... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,048 | +4,35 % | SOL Global Investments Corp.: SOL Global Announces Update on C$10 Million Debenture Private Placement from Strategic Investor | Toronto, Ontario--(Newsfile Corp. - March 21, 2025) - SOL Global Investments Corp. (CSE: SOL) (FSE: 9SB) ("SOL Global" or the "Company"), one of the first publicly traded companies focused on institutional... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,642 | -6,14 % | MustGrow Biologics Corp.: MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio | Saskatoon, Saskatchewan--(Newsfile Corp. - April 1, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,064 | 0,00 % | Entheon Biomedical Corp.: Entheon Issues Incentive Stock Options | Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that the Company has granted options... ► Artikel lesen | |
| CARA THERAPEUTICS | 4,610 | -100,00 % | Cara Therapeutics, Inc. - 8-K, Current Report | ||
| REVIVE THERAPEUTICS | 0,001 | -94,12 % | Revive Therapeutics Ltd.: Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program | TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| CYBIN | 5,350 | 0,00 % | Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights | TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental... ► Artikel lesen | |
| AWAKN LIFE SCIENCES | 0,074 | -100,00 % | Awakn Life Sciences Corp.: Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc | Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 0,890 | 0,00 % | Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025 | ||
| LOBE SCIENCES | 0,015 | -9,09 % | Lobe Sciences Ltd (2): Lobe Sciences receives U.S. Conjugated Psilocin patent |
Das Unternehmen RAPID DOSE THERAPEUTICS CORP kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.
